Amet minim mollit non deserunt

Upcoming Events

February 26 | 4:00-5:00 PM
Genomics-Driven Target Discovery In Metabolic disease with Dr. Melina Claussnitzer @ Harvard

February 28 | 11:00 AM to 2:30 PM
Osteoarthritis Science and Innovation Symposium @ Longwood Medical and Academic Area

March 4 | 3:15 - 4:15 PM
The Dangers of a Good Night's Sleep: Sleeping Pills, Dementia, Mortality with Dr. Charles Czeisler @ Harvard

Past Speakers

Alan Tomusiak, PhD

Chief Executive Officer, Stealth Biotechnology Company

Nir Barzilai, MD

Director, Institute for Aging Research, Albert Einstein College of Medicine

Joan Mannick, MD

Chief Executive Officer, Tornado Therapeutics

Matt Kaeberlein, PhD

Chief Executive Officer, Optispan

Steven Robinette, PhD

Chief Executive Officer, Spoila Therapeutics

Steve Horvath, PhD

Principal Investigator at Altos Labs

Michael Segel, PhD

Assistant Professor of Stem Cell and Regenerative Biology, Harvard University

Arthur Kleinman, MD

Professor, Medical Anthropology, Harvard Medical School

Paul Titchenell, PhD

Executive Director, Eli Lilly and Company

Sekar Kathiresan, MD

Senior Vice President, Eli Lilly and Company; Chief Executive Officer, Verve Therapeutics

Laura Deming

Founder and Chief Executive Officer, Until; Partner, age1 and The Longevity Fund

Eric Verdin, MD

President and Chief Executive Officer, Buck Institute for Research on Aging

Dylan Livingston

Founder and Chief Executive Officer, Alliance for Longevity Initiatives

Justin Olshavsky

Founder and General Partner, Pioneer Bio+Health Fund

Yang Huanming, PhD

Co-Founder and Board Member, BGI Group

Vadim Gladyshev, PhD

Professor of Medicine, Brigham and Women’s Hospital and Harvard Medical School

Jesse Poganik, PhD

Instructor in Medicine, Harvard Medical School

Kat Kajderowicz

PhD Candidate, MIT; Principal, age1

Alex Colville, PhD

Co-Founder and General Partner, age1

George Church, PhD

Professor of Genetics, Harvard Medical School; Serial Entrepreneur

Roger Fielding, PhD

Professor of Medicine, Tufts University School of Medicine

Douglas Kiel, MD, MPH

Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center

Shivani Sahni, PhD

Associate Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center

Yi-Hsiang Hsu, MD, ScD

Assistant Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center

Lada Nuzhna

Founder and Chief Executive Officer, Stealth Biotechnology Company; Director, Impetus Grants

Francisco LePort, PhD

Co-Founder and Chief Executive Officer, Gordian Biotechnology

David Glass, MD

Vice President, Research, Aging and Age-Related Disorders, Regeneron

Anne Ulrike-Trendelenburg, PhD

Director, Diseases of Aging and Regenerative Medicine, Novartis

Andrew Adams, PhD

Group Vice President, Molecule Discovery and Director, Institute of Genetic Medicines, Eli Lilly and Company

Ken Attie, MD

Vice President, Clinical Research, Obesity, Eli Lilly and Company; Chief Medical Officer, Versanis Bio

Brad Schoenfeld, PhD

Professor of Exercise Science, Lehman College

Jeff Nippard, PhD

Professional Bodybuilder; Science Communicator

Martin Jensen, PhD

Co-Founder and Chief Scientific Officer, Gordian Biotechnology; Co-Founder and President, Norn Group

Past Events

Speaker Events

Attendees learned from renowned experts who shared groundbreaking insights into aging science through inspiring keynotes and interactive Q&A sessions.

Attendees got an inside look at how computational biology is transforming aging research from Harvard Medical School investigator and co-director of the Biomarkers of Aging Consortium, Mahdi Moqri, PhD and participated in a hands-on demo using Biolearn, an open-source toolkit for biomarkers of aging data analysis.

CEO and Co-Founder Laura Deming, Head of Hardware John Bailey, and Chief Scientific Officer Hunter Davis, spoke about their work toward reversible cryopreservation for organ transplants and major milestones including a cryoprotective agent discovery engine, a custom electromagnet, and new cooling methods aimed at improving post-thaw organ function.

Dylan Livingston, who leads the Alliance for Longevity Initiatives (A4LI), the first U.S. nonprofit dedicated to advancing pro-longevity policies on Capitol Hill, spoke about translational aging policy and the new efforts in Washington that are shaping the future of aging research.

This session of the "Inside Aging" Nucleate Thematic Series covered the role of ventures and startups in the longevity biotech space. ft. Lada Nuzhna, Alex Colville, PhD, and Steve Robinette, PhD, and Justin Olshavsky, PhD

This session of the "Inside Aging" Nucleate Thematic Series focused on the use of aging clocks, omics technologies, and computational tools in aging research. ft. Steve Horvath, PhD, and Alan Tomusiak, PhD

In this "Inside Aging" Nucleate Thematic Series, Nir Barzilai, Joan Mannick, and Matt Kaeberlein discuss opportunities and necessary next steps for advancing therapeutics addressing the underlying mechanisms of aging as well as related physical and cognitive decline.

Participants learned from co-founders Laura Deming and Hunter Davis as well as members of the team discuss their story, progress thus far, and some of the most challenging outstanding technical problems. Participants also met and chat with team after presentation and Q&A.

This session of the "Inside Aging" Nucleate Thematic Series featured keynote speakers Eric Verdin and Martin Borch Jensen. This panel provided an overview of the aging biology field and the lanscape of longevity biotech. Viewers learned more about opportunities to get involved with this emergent space at the bench and beyond!

Professor Vadim Gladyshev explored the concept of the deleteriome—the accumulation of stress and damage during aging—and highlighted groundbreaking work on epigenetic clocks, revealing new targets and interactions implicated in aging.

Alex Colville, Ph.D., Co-founder of Age1, explored insights into navigating venture capital and biotech, with a Q&A session providing valuable perspectives for everyone from biotech enthusiasts to those involved in start-ups.

Professor Arthur Kleinman, M.D. led a thought-provoking discussion on the role of social technology—such as assistive and companion robotics, AI assistants, and biotech—in combating isolation, supporting caregivers, and enhancing mobility for aging populations.

The Aging Initiative kicked off an inspiring conversation and Q&A featuring Dr. George Church, HMS professor and founder of over 50 biotech companies, where attendees learned about aging, the organization’s goals, its future direction, and ways to get involved.

Dr. Yang Huanming, Co-founder of the Beijing Genomics Institute, shared insights as one of China’s leading genetic researchers and entrepreneurs. Attendees gained valuable perspectives on groundbreaking advancements in genomics and the global impact of genetic research.

Mixers, Conferences

Attendees connected with like-minded peers, leading researchers, and industry professionals to explore innovative ideas and build collaborations in the aging field.

The Future of Aging Research (FAR) Mixer 2025 is Boston's premier mixer that aims to bring together undergraduate and graduate student researchers specializing in various biotechnology and aging-related disciplines under one roof to learn from experienced pioneers in the field of aging biology. Note: registration approval is required to attend!Learn more here

The Muscle Aging Science & Translation (MAST) Symposium, hosted by the Harvard Aging Initiative and the Norn Group, catalyzed education, research, and innovation towards frailty, age-related muscle loss, and associated diseases.Learn more here

The Future of Aging Research Mixer is a one-day mixer event that brings together the younger generations of Boston’s aging researchers and enthusiasts to enable students to connect with each other, fostering collaboration, sharing ideas, and exposing the most pertinent questions in the field of aging.
Learn more here

Journal Clubs, Workshops, Professional Dinners

Attendees engaged in insightful discussions and valuable networking opportunities with experts in the aging field.

Participants discussed an exciting paper on reproductive agingThis is a great opportunity to connect with other students and researchers in the field of longevity, accompanied by thought-provoking discussion, and lots of pizza!

Participants explored new approaches to tackling age-related diseases with industry veterans, startup founders, investors, and expert academics pioneering our understanding of the field.
‍
Learn more here

Students and researchers gathered for an engaging discussion on the paper "Traumatic Brain Injury Promotes Neurogenesis at the Cost of Astrogliogenesis in the Adult Hippocampus of Male Mice."

The session was filled with thought-provoking debates, exciting insights, and pizza!

Professor Dinner ft. Dr. Jonathan Gootenberg and Dr. Omar Abudayyeh

Students engaged in thought-provoking conversations about aging and related research in a small, focused setting with Dr. Jonathan Gootenberg and Dr. Omar Abudayyeh.

Location: Russel House Tavern

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Past Speakers

Speaker Events

Dylan Livingston, who leads the Alliance for Longevity Initiatives (A4LI), the first U.S. nonprofit dedicated to advancing pro-longevity policies on Capitol Hill, spoke about translational aging policy and the new efforts in Washington that are shaping the future of aging research.

​This session of the "Inside Aging" Nucleate Thematic Series covered the role of ventures and startups in the longevity biotech space. ft. Lada Nuzhna, Alex Colville, PhD, and Steve Robinette, PhD, and Justin Olshavsky, PhD

​This session of the "Inside Aging" Nucleate Thematic Series focused on the use of aging clocks, omics technologies, and computational tools in aging research. ft. Steve Horvath, PhD, and Alan Tomusiak, PhD

In this "Inside Aging" Nucleate Thematic Series, Nir Barzilai, Joan Mannick, and Matt Kaeberlein discuss opportunities and necessary next steps for advancing therapeutics addressing the underlying mechanisms of aging as well as related physical and cognitive decline.

Participants learned from co-founders Laura Deming and Hunter Davis as well as members of the team discuss their story, progress thus far, and some of the most challenging outstanding technical problems.​ Participants also met and chat with team after presentation and Q&A.

Professor Vadim Gladyshev explored the concept of the deleteriome—the accumulation of stress and damage during aging—and highlighted groundbreaking work on epigenetic clocks, revealing new targets and interactions implicated in aging.

Alex Colville, Ph.D., Co-founder of Age1, explored insights into navigating venture capital and biotech, with a Q&A session providing valuable perspectives for everyone from biotech enthusiasts to those involved in start-ups.

Professor Arthur Kleinman, M.D. led a thought-provoking discussion on the role of social technology—such as assistive and companion robotics, AI assistants, and biotech—in combating isolation, supporting caregivers, and enhancing mobility for aging populations.

The Aging Initiative kicked off an inspiring conversation and Q&A featuring Dr. George Church, HMS professor and founder of over 50 biotech companies, where attendees learned about aging, the organization’s goals, its future direction, and ways to get involved.

Dr. Yang Huanming, Co-founder of the Beijing Genomics Institute, shared insights as one of China’s leading genetic researchers and entrepreneurs. Attendees gained valuable perspectives on groundbreaking advancements in genomics and the global impact of genetic research.

Mixers, Conferences

​​The Muscle Aging Science & Translation (MAST) Symposium, hosted by the Harvard Aging Initiative and the Norn Group, catalyzed education, research, and innovation towards frailty, age-related muscle loss, and associated diseases.Learn more here

Journal Clubs, Workshops, Professional Dinners

​Participants discussed an exciting paper on reproductive agingThis is a great opportunity to connect with other students and researchers in the field of longevity, accompanied by thought-provoking discussion, and lots of pizza!

Participants explored new approaches to tackling age-related diseases with industry veterans, startup founders, investors, and expert academics pioneering our understanding of the field. ‍Learn more here

Students and researchers gathered for an engaging discussion on the paper "Traumatic Brain Injury Promotes Neurogenesis at the Cost of Astrogliogenesis in the Adult Hippocampus of Male Mice." The session was filled with thought-provoking debates, exciting insights, and pizza!

Professor Dinner ft. Dr. Jonathan Gootenberg and Dr. Omar Abudayyeh

Students engaged in thought-provoking conversations about aging and related research in a small, focused setting with Dr. Jonathan Gootenberg and Dr. Omar Abudayyeh. Location: Russel House Tavern

This session of the "Inside Aging" Nucleate Thematic Series covered the role of ventures and startups in the longevity biotech space. ft. Lada Nuzhna, Alex Colville, PhD, and Steve Robinette, PhD, and Justin Olshavsky, PhD

This session of the "Inside Aging" Nucleate Thematic Series focused on the use of aging clocks, omics technologies, and computational tools in aging research. ft. Steve Horvath, PhD, and Alan Tomusiak, PhD

Participants learned from co-founders Laura Deming and Hunter Davis as well as members of the team discuss their story, progress thus far, and some of the most challenging outstanding technical problems. Participants also met and chat with team after presentation and Q&A.

The Muscle Aging Science & Translation (MAST) Symposium, hosted by the Harvard Aging Initiative and the Norn Group, catalyzed education, research, and innovation towards frailty, age-related muscle loss, and associated diseases.Learn more here

Participants discussed an exciting paper on reproductive agingThis is a great opportunity to connect with other students and researchers in the field of longevity, accompanied by thought-provoking discussion, and lots of pizza!

Participants explored new approaches to tackling age-related diseases with industry veterans, startup founders, investors, and expert academics pioneering our understanding of the field.
‍
Learn more here

Students and researchers gathered for an engaging discussion on the paper "Traumatic Brain Injury Promotes Neurogenesis at the Cost of Astrogliogenesis in the Adult Hippocampus of Male Mice."

The session was filled with thought-provoking debates, exciting insights, and pizza!

Students engaged in thought-provoking conversations about aging and related research in a small, focused setting with Dr. Jonathan Gootenberg and Dr. Omar Abudayyeh.

Location: Russel House Tavern